Triple combination chemotherapy of disseminated melanoma.
D000368:Aged; D000477:Alkylating Agents; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects; D002330:Carmustine / Q000008:administration & dosage; D002986:Clinical Trials as Topic; D004338:Drug Combinations / Q000009:adverse effects; D005069:Evaluation Studies as Topic; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007093:Imidazoles / Q000008:administration & dosage*; D007970:Leukopenia / Q000139:chemically induced; D008175:Lung Neoplasms / Q000000981:diagnostic imaging; D008297:Male; D008545:Melanoma / Q000188:drug therapy*; D008875:Middle Aged; D009362:Neoplasm Metastasis; D009603:Nitroso Compounds / Q000008:administration & dosage*; D011859:Radiography; D012878:Skin Neoplasms / Q000188:drug therapy*; D013921:Thrombocytopenia / Q000139:chemically induced; D014508:Urea / Q000008:administration & dosage*; D014750:Vincristine / Q000008:administration & dosage*
D000477:Alkylating Agents; D000970:Antineoplastic Agents; D004338:Drug Combinations; D007093:Imidazoles; D009603:Nitroso Compounds; D014750:Vincristine; D014508:Urea; D002330:Carmustine